Cargando…
EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of Glioblastoma
Epidermal growth factor receptor variant III (EGFRvIII) is a tumor-specific cell surface antigen often expressed in glioblastoma and has drawn much attention as a possible therapeutic target. We performed immunohistochemistry on histology sections of surgical specimens taken from 67 cases with gliob...
Autores principales: | NOZAWA, Takanori, OKADA, Masayasu, NATSUMEDA, Manabu, EDA, Takeyoshi, ABE, Hideaki, TSUKAMOTO, Yoshihiro, OKAMOTO, Kouichirou, OISHI, Makoto, TAKAHASHI, Hitoshi, FUJII, Yukihiko, KAKITA, Akiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434422/ https://www.ncbi.nlm.nih.gov/pubmed/30787232 http://dx.doi.org/10.2176/nmc.oa.2018-0078 |
Ejemplares similares
-
COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA
por: Tsukamoto, Yoshihiro, et al.
Publicado: (2019) -
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
por: Abe, Hideaki, et al.
Publicado: (2020) -
Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas
por: On, Jotaro, et al.
Publicado: (2021) -
EGFRvIII: the promiscuous mutation
por: Greenall, Sameer A, et al.
Publicado: (2016) -
Successful Treatment of Acute Uric Acid Nephropathy with Rasburicase in a Primary Central Nervous System Lymphoma Patient Showing a Dramatic Response to Methotrexate—Case Report
por: Mouri, Yoshihiro, et al.
Publicado: (2022)